comparemela.com

Latest Breaking News On - Midatech pharma plcview - Page 1 : comparemela.com

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines

United kingdomUnited statesCity ofMatthew chandler rob patrickMidatech pharma plcviewDmitry zamoryakhinTim metcalfe grahamEdison group us investor relationsStrand hanson limited nominated adviserLondon stock exchangeMidatech pharmaAdvisory limited financialExchange commissionChemoresistant ovarianIntj molHanson limited

Midatech Pharma PLC Announces Results of General Meeting

Share Consolidation, Change of Name, Adoption of New Articles and Cancellation of Admission to Trading on AIMABINGDON, OXFORDSHIRE / ACCESSWIRE / March 24, 2023 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP)

City ofUnited kingdomUnited statesMatthew chandler rob patrickMidatech pharma plcviewTim metcalfe grahamCompany the ordinaryMidatech pharmaLondon stock exchangeCompany american depositary shares adssCompany shareholderFinancial conduct authorityEuropean union withdrawalStrand hanson limited nominated adviserAdvisory limited financialEdison group us investor relations

Midatech Pharma PLC Announces Closing of $6 0m Private Placement & Broker Change

ABINGDON, UK / ACCESSWIRE / February 15, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines

United statesUnited kingdomCity ofDennis riedlMidatech pharma plcviewMatthew chandler rob patrickLondon stock exchangeStrand hanson limited nominated adviserCompany nominated adviserFinancial conduct authorityExchange commissionLadenburg thalmann coStrand hanson limitedMidatech pharmaPrivate placementAmerican depository share

Midatech Pharma PLC Announces Private Placement Raising US $6 0 million

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN (THE "ANNOUNCEMENT") IS RESTRICTED AND IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO CANADA

United statesUnited kingdomCity ofMidatech pharma plcviewSchwierige zeitenMatthew chandler rob patrickInternational financial reporting standardsLondon stock exchangeCompany adssStrand hanson limited nominated adviserFinancial conduct authorityShareholder authorityExchange commissionLondon stock exchange for the placingLadenburg thalmann coPlacement agency agreement

Midatech Pharma PLC Announces Receipt of NASDAQ Notice

ABINGDON, OXFORDSHIRE / ACCESSWIRE / February 3, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines

United statesUnited kingdomCity ofMidatech pharma plcviewTim metcalfe grahamSchwierige zeitenMatthew chandler rob patrickAndrew thacker james popeLtd joint brokerLondon stock exchangeStrand hanson limited nominated adviserFinancial conduct authorityMarket of the london stock exchangeExchange commissionCompany american depositary shares theStock market

vimarsana © 2020. All Rights Reserved.